PATIENT ENGAGEMENT

Patient Organization

Lufthansa flies a cargo plane with cargo on it.

The patient comes first

For Bayer, one of the world's leading specialty pharmaceutical companies, patients' health always comes first. Exchanging ideas and information with patient organizations on the basis of mutual trust is an important component of our work.

 

Such cooperation helps us to understand the needs of patients as they come to terms with their illness. This enables us to gear our research and development to these needs and to continue working on improved, new drugs and therapies.

 

Bayer cooperates with patient organizations in all kinds of therapeutic areas. We attach great importance to transparency in this context and protect the independence of our cooperation partners.

 

Our principles

Cooperation between Bayer and patient organizations is based on the following principles.

  1. In order to provide patients with quality medical healthcare, a partnership with a patient organization pursues a specific objective concentrating on one or more of the following areas:
    • raising awareness for certain diseases by improving diagnostic possibilities and preventive measures, knowing the patients' prospects and needs,
    • understanding diseases and making sure that patients receive the best medical treatment available,
    • improving the information provided to the patients,
    • supporting medical innovations.
  2. Bayer and the patient organizations comply with international and national laws and regulations.
  3. Cooperation with a patient organization should neither influence decisions on a therapy nor promote or support specific therapies.
  4. Bayer respects the neutrality and independence of patient organizations. Cooperation is based on a partnership between equals in which transparency and clarity are fundamental principles. This is why we also provide information on the extent and nature of support.

 

Overview of cooperation with patient organizations in Europe in 2022

The following is a list of patient organizations with which Bayer and its affiliated companies in Europe cooperated in 2022.

 

Headquarters:

Bayer Company

Bayer AG

Contract date

03.09.2022

Amount

18.850 EUR

Purpose of interaction

Recruit a minimum of four patients and eight caregivers to help co-create and inform the development team of a "matching" feature to be implemented on the Bayer Vital patient portal.

 

Bayer Company

Bayer AG

Contract date

28.02.2022

Amount

675 EUR

Purpose of interaction

Bayer AG wishes to engage a Kidney Patient Council team member already recruited by Patient in Focus to participate in a Kidney Health Podcast on the topic of early chronic kidney disease and barriers to communication. The Kidney Health Podcast will take place within 6 weeks from this proposal.

Bayer Company

Bayer AG

Contract date

23.09.2022

Amount

30.000 EUR

Purpose of interaction

Co-operation Agreement: Strategic Corporate Partnership

 

Bayer Company

Bayer AG

Contract date

07.11.2022

Amount

63.000 EUR

Purpose of interaction

IDF Congress

 

Bayer Company

BCC AG

Contract date

2022

Amount

40.000 EUR

Purpose of interaction

Annual Sponsorship

 

Bayer Company

Bayer AG

Contract date

24.11.2022

Amount

900 EUR

Purpose of interaction

AdBoard Meeting "IC/BPS" - "Participation of Barbara Jankowski Patient perspective on interstitial cystitis/bladder pain syndrome"

 

Bayer Company

Bayer AG

Contract date

17.11.2022

Amount

600 EUR

Purpose of interaction

AdBoard Meeting "IC/BPS" - "Participation of Barbara Jankowski Patient perspective on interstitial cystitis/bladder pain syndrome"

 

Bayer Company

Bayer AG

Contract date

17.10.2022

Amount

20.000 EUR

Purpose of interaction

Provision of expert advice and co-creation of patient education materials.
Provision of patient experience expertise in specific European countries.
Organization of focus groups with patient representatives on topics of shared interest.

 

Bayer Company

BCC AG

Contract date

21.10.2022

Amount

225 EUR

Purpose of
interaction

European Patient Council (Hematology)

 

Bayer Company

BCC AG

Contract date

2022

Amount

94.760 EUR

Purpose of interaction

Annual Sponsorship

 

Bayer Company

BCC AG

Contract date

2022

Amount

20.000 GBP

Purpose of interaction

World Sight Day Sponsorship

 

Bayer Company

BCC AG

Contract date

2022

Amount

8.046,60 CHF

Purpose of interaction

Travel arrangements Singapore Joint Meeting 2022

 

Bayer Company

BCC AG

Contract date

2022

Amount

398,25 CHF

Purpose of interaction

Travel arrangements EURETINA 2022

Europe: 

Reports can be received from

UAB Bayer Baltic Republics (Estonia, Latvia, Lithuania) 
Alina Tikuišiene MD
Zirmunu str. 68A 
LT-09124 Vilnius/Lithunia
 

Reports can be received from    

UAB Bayer Baltic Republics (Estonia, Latvia, Lithuania) 
Alina Tikuišiene MD
Zirmunu str. 68A 
LT-09124 Vilnius/Lithunia
 

Reports can be received from    

Bayer AB- Bayer Scandinavia
Iina Wargh
Gustav III:s Boulevard 56
169 26 Solna

Reports can be received from    

SC Bayer SRL 
Bayer Pharmaceuticals Division 
Sos. Pipera nr. 42., Sector 2 
NUSCO Tower fl. 1,16,17 
020112, Bucharest
Romania

Reports can be received from    

Bayer Pharma d.o.o. 
Jelena Tokanovic
Omladinskih brigada 88b
Belgrade

Reports can be received from    

Bayer d.o.o. 
Lucija Zlodi Gosnik
Bravnicarjeva 13
1000 Ljubljana